(Reuters) - Pravachol has annual sales of over $861 million, Glenmark said in a statement.
) Keywords: GLENMARK FDA/
Read more at Reuters.com Government Filings News
Subscribe to:
Post Comments (Atom)
The Longs and the Shorts of my trading on the JSE. My thoughts, actions and rambelings while trading. The thing I love best!
Could not find what you where looking for?
Books I Suggest
FTSE/JSE Indices
Commodities
Blog Archive
-
▼
2007
(2780)
-
▼
May
(664)
-
▼
May 16
(21)
- US panel: MedImmune's FluMist works for young kids
- Morocco's Main Index Gains, Paced by Maroc Telecom...
- UPDATE 1-Hedge fund differences not that great-Canada
- Unilever's Treschow to talk with investors before ...
- Oil Declines on Signs Gasoline Supplies May Rise; ...
- Mexican Peso Rises to 4-Month High on Inflows Afte...
- David Thomson Snares Biggest-Ever Canadian Takeove...
- BNP Paribas Hires U.S. Treasury Bond Trader Rick K...
- Gold, Silver Futures Fall in New York as Dollar St...
- Copper Slumps in New York on Speculation Chinese M...
- Stock Investors Are Most Optimistic on Earnings in...
- UPDATE 1-FirstService reports lower profit, ups fo...
- RPT-UPDATE 2-Africa Development Bank says must ref...
- Autogrill wins deals worth $242 mln at JFK airport
- REFILE-Union threat to Blackstone IPO plans - report
- South Africa's Finance Minister Says Wolfowitz Sho...
- FDA food safety plan got cold reception: WSJ
- Julius Baer Stock Jumps on Speculation Deutsche Ba...
- U.S. could still have 2.7 pct growth in '07: adviser
- Alon USA Energy Will Shut Down Unit Today at Refin...
- India Glenmark gets US nod for pravastatin sodium
-
▼
May 16
(21)
-
▼
May
(664)
About Me
- Corne'
- By day I write code and at night I trade. Wel I trade in beteen the writing of the code but that would not sound cool. Also studying to become a stockbroker.
No comments:
Post a Comment